Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial
Fig 1
Phase A patients were treated with either Tyloxapol or saline for 21 days at three inhalations a day. After a wash-out phase of 7 days, Phase B started. Patients were switched to the other medication for another 21 days.